FSANZ CEO Reflects on Key Regulatory Shifts Impacting ANZ Food & Supplement Sectors

FSANZ's Year of Foundational Regulatory Updates for ANZ

As 2025 concluded, the Food Standards Australia New Zealand (FSANZ) CEO, Dr. Sandra Cuthbert, issued a comprehensive review of the year's regulatory achievements. This annual reflection provides critical insights for supplement manufacturers and brand owners, detailing progress in ensuring food safety and adapting to evolving industry landscapes across Australia and New Zealand.

A notable update from FSANZ includes strengthened national standards for egg production and processing. While primarily affecting the broader food industry, such foundational changes in food safety protocols can sometimes cascade into ingredient sourcing for specific supplement formulations, particularly those utilising egg-derived components. From a manufacturing perspective, these updates underscore the continuous need for robust quality control and supplier vetting, ensuring all raw materials conform to the latest safety benchmarks.

Innovation and Labelling: Key Changes for the Supplement Industry

Perhaps more directly relevant to the supplement sector are the updates to genetically modified (GM) food definitions. This revision brings the Food Standards Code in line with contemporary scientific understanding, an area of significant interest for formulators exploring novel ingredients or using components derived from biotechnological processes. For manufacturers like us at Supplement Factory, this means ensuring our private label and custom formulations accurately reflect these new definitions, particularly concerning ingredient declarations and consumer transparency. Brand owners should proactively review their product portfolios to comply with these updated guidelines, avoiding potential regulatory headwinds.

A significant milestone highlighted by FSANZ was the approval of cultured quail as the first cell-cultured food in Australia and New Zealand. This pioneering approval is a clear signal of FSANZ's progressive stance on novel foods and ingredients. While currently limited to food products, this sets a crucial precedent for future alternative protein sources and bio-engineered components that could eventually find their way into the supplement market. For forward-thinking manufacturers, this opens doors for potential future ingredient diversification and innovative product development.

Moreover, the CEO's review touched upon advancing preparatory work on front- and back-of-pack nutrition labelling. Although specific details for supplements were not explicitly stated, the general push towards enhanced nutritional transparency aligns with global consumer demand for clearer product information. Brand owners should anticipate stricter or more comprehensive labelling requirements in the future, making robust data management and accurate nutritional analysis from their contract manufacturers essential.

International Collaboration and Future Outlook

FSANZ also highlighted its continued international engagement, including a shared assessment process with Health Canada for GM food applications. This collaborative model demonstrates an effort to streamline regulatory processes while maintaining high safety standards, which can ultimately expedite market access for safe and innovative products. For manufacturers eyeing both ANZ and Canadian markets, such alignment is beneficial.

Looking ahead, food ministers have endorsed FSANZ's roadmap to 2030, outlining a five-year plan that includes an evaluation framework for standards, digital labelling, and an international alignment review. The mention of digital labelling is particularly pertinent for the supplement industry, suggesting a shift towards more dynamic and accessible product information. Contract manufacturers and brand owners will need to adapt their information systems and labelling strategies to meet these forthcoming digital demands. This strategic plan suggests a continued evolution in regulatory oversight, urging all industry stakeholders to remain agile and informed.

For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.